Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Trading Update

6 Jul 2017 07:00

RNS Number : 2582K
Swallowfield PLC
06 July 2017
 

6 July 2017

Swallowfield plc

("Swallowfield" or the "Group")

 

Trading update and notice of results

 

Swallowfield plc, a market leader in the development, formulation, and supply of personal care and beauty products, including its own portfolio of brands, is pleased to provide a trading update for the 52 weeks ended on 24 June 2017.

 

Trading update

 

The Board is pleased to confirm that the business has continued to trade strongly. Overall revenues for the full year are expected to show growth of 36% (30% on a constant currency basis) to approximately £74.1m (2016: £54.5m). Revenues excluding acquisitions are expected to show a growth of 7% (2% on a constant currency basis).

 

Revenue growth has been bolstered by the continuing strong performance of owned brands, in particular, the Brand Architekts' portfolio acquired in June 2016. In the Group's manufacturing business, revenues continued to perform solidly on the back of a stream of innovative new product launches.

 

As a result, underlying business performance* is expected to be significantly ahead of the previous year and in line with market forecasts.

 

The Group's balance sheet has further strengthened during the period with strong cash generation and working capital controls leading to a net debt position of £3.7m as at 24 June 2017 (2016: £4.3m). This figure includes a term loan of £2.0m used as part of the financing for the acquisition of The Brand Architekts.

 

Chris How, Chief Executive of Swallowfield, commented:

 

"Whilst the retail and consumer markets remain challenging, it has been a year of tremendous progress for the Group with the successful execution of our stated strategy driving us to record levels of sales and underlying profitability. The acquisition of The Brand Architekts has delivered fully against our expectations and has been integrated smoothly and effectively into the Group. The manufacturing business continues to perform solidly in its own right and provide crucial support to the growth of our owned brands."

 

Notice of results

 

The Company expects to announce its results for the 52-week period ended 24 June 2017 on 19 September 2017.

 

* Underlying business performance is adjusted for the impact of provisions made in relation to long term share based incentives (anticipated to be approximately £1.7m) and amortisation of acquisition-related intangibles. The majority of the charge on share based incentives relates to awards made in 2014 and become exercisable towards the end of 2017. These share options were put in place in order to incentivise the Group's wider management team (including the executive directors of Swallowfield) and to ensure that their interests are aligned with shareholders. At the time, this incentive plan was introduced the average share price was 95p and since that time shareholders have been rewarded with a capital improvement of over 300% in addition to progressive dividend income.

 

For further information please contact:

Swallowfield plc

Chris How

 Chief Executive Officer

 01823 662 241

Mark Warren

 Group Finance Director

 01823 662 241

Alex Price

 N+1 Singer

 020 7496 3000

Josh Royston / Hilary Buchanan

 Alma PR

 020 8004 4218

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRAMMTMBMMTBR
Date   Source Headline
25th Feb 20107:00 amRNSHalf Yearly Report
19th Feb 20102:31 pmRNSHolding(s) in Company
27th Jan 201012:29 pmRNSHolding(s) in Company
3rd Dec 20093:20 pmRNSDirectorate Change
18th Nov 20094:28 pmRNSHolding(s) in Company
13th Nov 20093:17 pmRNSHolding(s) in Company
5th Nov 20093:28 pmRNSAGM Statement
3rd Nov 200912:05 pmRNSDirectorate Change
27th Oct 20094:33 pmRNSTotal Voting Rights
15th Oct 20092:06 pmRNSExercise of options and Directors' dealing
8th Oct 20094:37 pmRNSPosting of Annual Report and Accounts
10th Sep 20097:00 amRNSFinal Results
26th Feb 20097:00 amRNSHalf Yearly Report
12th Jan 20097:00 amRNSChange of Adviser
24th Nov 20084:24 pmRNSDirector/PDMR Shareholding
7th Nov 20087:00 amRNSAGM Statement
16th Oct 20081:50 pmRNSHolding(s) in Company
13th Oct 20084:41 pmRNSAnnual Report and Accounts
13th Oct 200810:13 amRNSDirectorate Change
17th Sep 200811:15 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSDirector/PDMR Shareholding
11th Sep 20087:00 amRNSFinal Results
5th Sep 200810:00 amRNSNotice of Results
15th Jul 20087:00 amRNSRe Joint Venture
2nd Jun 200812:07 pmRNSHolding(s) in Company
28th Feb 20087:01 amRNSInterim Results
15th Jan 200811:36 amRNSHolding(s) in Company
11th Jan 20087:01 amRNSNew Cosmetics Operation
10th Jan 20083:49 pmRNSDirector/PDMR Shareholding
7th Jan 200810:34 amRNSDirector/PDMR Shareholding
28th Dec 200711:38 amRNSSale and Leaseback
8th Nov 20072:43 pmRNSAGM Statement
7th Nov 20074:10 pmRNSHolding(s) in Company
2nd Nov 20075:31 pmRNSre nomination of directors
2nd Nov 20077:00 amPRNStatement re nomination of new Swallowfield directors
17th Oct 200711:33 amRNSDirector/PDMR Shareholding
16th Oct 20073:30 pmRNSAnnual Report and Accounts
15th Oct 20077:01 amRNSDirectorate Change
12th Oct 20073:48 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSFinal Results
5th Sep 200710:29 amRNSHolding(s) in Company
17th Aug 20074:46 pmRNSAIM Rule 26
15th Jun 20073:45 pmRNSHolding(s) in Company
6th Jun 20077:01 amRNSTrading Statement
18th May 20074:29 pmRNSHolding(s) in Company
17th May 200712:21 pmRNSTrading Update
23rd Apr 200710:56 amRNSHolding(s) in Company
13th Apr 20072:47 pmRNSHolding(s) in Company
2nd Mar 20077:30 amRNSInterim Results
6th Feb 200712:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.